Gerard Griffioen
Hoofd Techniek/Wetenschap/O&O bij reMYND NV
Actieve functies van Gerard Griffioen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van Gerard Griffioen
Eerdere bekende functies van Gerard Griffioen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Katholieke Universiteit Leuven | Corporate Officer/Principal | - | - |
| University of Vienna | Corporate Officer/Principal | - | - |
Opleiding van Gerard Griffioen
| Vrije Universiteit Amsterdam | Doctorate Degree |
Statistieken
Internationaal
| België | 3 |
| Verenigd Koninkrijk | 2 |
| Oostenrijk | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Consumer Services | 4 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Commercial Services |
- Beurs
- Insiders
- Gerard Griffioen
- Ervaring
